RenovoRx announces new clinical data on TAMP therapy platform

RenovoRx (RNXT) announced that new clinical data will be presented at the 2026 Society of Interventional Oncology, SIO, Annual Scientific Meeting on February 6, 2026. The clinical data abstract entitled, “Real-Time Intravascular Pressure Measurements During Double Balloon Catheter-Mediated Trans-Arterial Micro-Perfusion to Optimize Drug Delivery in Solid Tumors,” was led by Christopher Laing, MD of Sutter Health in California. The study explores a simplified method for measuring intra-arterial pressure during procedures that use the TAMP therapy platform enabled by the RenovoCath catheter. The findings in this study demonstrate that a simplified, external pressure transducer provides reliable and reproducible intra-arterial pressure measurements during TAMP procedures, with strong correlation to intravascular pressure wire measurements in a porcine model.